T2 Biosystems, Inc. recently announced that its T2SARS-CoV-2™ Panel, a molecular diagnostic test that detects SARS-CoV-2, can detect the Brazil (P.1) variant of the SARS-CoV-2 virus. This expands the utility of its panel to reliably detect newer variants that have emerged in United Kingdom (B.1.1.7)...
IZEA Worldwide, Inc. (NASDAQ: IZEA), a premier marketing technology Company, announced that it has been awarded expansion of a military contract, that was originally signed in November 2020. The mid-six figure contract was the largest ever received by the company from a federal agency, and...
TherapeuticsMD (NASDAQ: TXMD), is a women’s healthcare Company focused on creating novel solutions for challenges encountered by women in areas such as family planning, reproductive health, and menopause management. The Company’s product offerings include Annovera, a progestin/estrogen CHC vaginal birth control ring intended for contraception,...
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) is developing innovative approaches that help modulate the immune system to combat, ocular, fibrosis and Cytokine release syndrome. The Company recently released topline results from a Phase III trial of Reproxalap being developed for the treatment of dry eye syndrome....
Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is in the spotlight after receiving a “Buy” rating along with a $30 price target from Ram Selvaraju an analyst at H.C Wainwright, implying a nearly 275% upside from its current levels. We take a look at reasons for the...
BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device Company leveraging its signal processing technology platform, announced its partnership with Vuzix® Corporation (NASDAQ: VUZI), to deploy Vuzix’s M400 Smart Glasses for remote servicing, installations, upgrades and training of its PURE EP™ System, to support a nationwide...
The Pandemic has had a tremendous impact on the Diagnostics Industry, with increased demand for stringent testing across the world. According to a report by Research and Markets, the Global in-vitro diagnostics market is expected to reach USD 96.0 billion by 2025, growing at a CAGR of...
Bionano Genomics, Inc. (NASDAQ: BNGO), creator of the leading-edge optical genome mapping platform, Saphyr, announced that Lineagen, its diagnostic services subsidiary has achieved the most comprehensive analysis of the genome of high functioning individual with Autism Spectrum Disorder (ASD). The subject of the study is...
Remark Holdings, Inc. (NASDAQ: MARK), a Company delivering cutting-edge AI solutions, announced that one of the largest commercial banks in China has chosen KANKAN AI, its data intelligence platform, which provides AI-based products and software-as-a-service solutions for a wide-range of industries, to install the Smart...
Novan, Inc. (NASDAQ: NOVN), a clinical–stage Biotechnology Company leveraging its expertise in nitric oxide-based therapies, has entered into a Master Services Agreement (MSA) with Catalent for supporting the development and chemistry, manufacturing and control (CMC) activities for berdazimer sodium, to be made into an intranasal...
